| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/29/2009 | CN100518747C Matrix metalloprotease inhibitor |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566742 phosphoprotein preparation comprises a partially cross-linked partial hydrolysate of casein; a source of calcium ions; and a source of phosphate ions, or a source of strontium ions; calcium phosphate |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/28/2009 | CA2447329C 1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/28/2009 | CA2408537C Treating irritable bowel syndrome or disease |
| 07/28/2009 | CA2387787C Nutritional composition for treating inflammatory bowel diseases |
| 07/28/2009 | CA2315235C Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same |
| 07/23/2009 | WO2009091052A1 Food having therapeutic effect on decay at the early stage and therapeutic kit for decay at the early stage |
| 07/23/2009 | WO2009091050A1 Composition for oral application |
| 07/23/2009 | WO2009090970A1 Liver function-protecting agent |
| 07/23/2009 | WO2009090961A1 Agent for prevention of alcoholic hepatopathy |
| 07/23/2009 | WO2009089702A1 Stable 6-methoxy-2',3'-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same |
| 07/23/2009 | WO2009073648A3 Compositions and methods for regulating entamoeba histolytica function |
| 07/23/2009 | WO2009037262A3 Method of preventing early lawsonia intracellularis infections |
| 07/23/2009 | WO2009026158A3 Inflammation-regulating compositions and methods |
| 07/23/2009 | WO2008149154A3 Tegaserod succinate and polymorphic forms |
| 07/23/2009 | WO2008143527A8 Probiotic bacterium |
| 07/23/2009 | WO2008127591A3 Pyrimidinedione derivatives and use thereof |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186852 Tri- and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 07/23/2009 | US20090186833 Method for producing pectin hydrolysis products |
| 07/23/2009 | US20090186813 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 07/23/2009 | US20090186108 Extract of herbal and composition containing the same |
| 07/23/2009 | US20090186106 Pharmaceutical composition for use as a laxative |
| 07/23/2009 | US20090186090 Oral Care Composition to Reduce or Eliminate Dental Sensitivity |
| 07/23/2009 | US20090186084 Form of administration of racecadotril |
| 07/23/2009 | US20090186079 Oral and overall health by negating the biological effects of bacterial lipids |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/23/2009 | US20090185996 Hydroxyethyl starch-containing polypeptide compositions |
| 07/23/2009 | US20090185987 Herbal dental care composition, method of manufacturing the same and use thereof |
| 07/23/2009 | US20090185986 Application of natural mineral water with special qualities in prophylaxis, hygiene and treatment of teeth and paradontium |
| 07/23/2009 | DE102008005484A1 Induktion und Förderung der Arteriogenese Induction and promotion of arteriogenesis |
| 07/23/2009 | CA2711532A1 Agent for prevention of alcoholic hepatopathy |
| 07/23/2009 | CA2618380A1 Feed additive and uses thereof |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2079676A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 07/22/2009 | EP2079525A1 Calcium receptor modulating agents |
| 07/22/2009 | EP2079468A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 07/22/2009 | EP2012768A4 Oral patch with salt of glycyrrhetinic acid water soluble at human mouth temperatures |
| 07/22/2009 | EP1499290B1 Warming and nonirritating lubricant compositions |
| 07/22/2009 | EP1492761B1 Amino acids with affinity for the alpha-2-delta-protein |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |
| 07/22/2009 | CN101486677A 5HT2c receptor modulators |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516204C Stem cells and method of separating the same |
| 07/22/2009 | CN100516203C In vitro cell culturing method |
| 07/22/2009 | CN100516066C Compounds for treating impaired fundic relaxation |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/21/2009 | US7563895 Quinoxaline compounds |
| 07/21/2009 | US7563872 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds |
| 07/21/2009 | US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/21/2009 | US7563458 Nutritional compositions for nutritional management of patients with liver disease |
| 07/21/2009 | US7563456 Process for preparation of programmed liberation composition with venlafaxine and the resulting product |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/21/2009 | CA2382098C Sustained-release, oral pharmaceutical forms of administration |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009089234A2 Substituted dibenzhydrylpiperazines |
| 07/16/2009 | WO2009088879A1 Combinations to improve animal health and performance |
| 07/16/2009 | WO2009088857A1 Crystalline solvated forms of (r) -2- [ [ [3-methyl-4- (2, 2, 2-trifluoroethoxy) -2-pyridinyl] methyl] sulfinyl] -1h-benz imidazole |
| 07/16/2009 | WO2009087602A1 Compositions for use in the treatment and prevention of ulcerative collitis |
| 07/16/2009 | WO2009087285A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/16/2009 | WO2009087263A1 Composition for improving liver metabolism and diagnostic method |
| 07/16/2009 | WO2009086920A1 Anti mif antibodies |
| 07/16/2009 | WO2009086731A1 New benzimidazole compounds |
| 07/16/2009 | WO2009065946A3 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 07/16/2009 | WO2009043856A3 Modulation of tissue fatty acid composition of a host by human gut bacteria |
| 07/16/2009 | WO2008000028A8 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 07/16/2009 | WO2007135390A8 Prevention of plaque formation |
| 07/16/2009 | US20090182062 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090182056 Pharmaceutical formulations of amyloid inhibiting compounds |
| 07/16/2009 | US20090182055 Fungicidal agent containing n-chlorotaurine and use thereof |
| 07/16/2009 | US20090182052 Taste-masked docusate compositions |
| 07/16/2009 | US20090182047 Utilization of dialkylfumarates |
| 07/16/2009 | US20090182033 Cyclic Amine Derivatives and Their Uses |
| 07/16/2009 | US20090182022 Treatment of Fatty Liver |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181940 Imidazopyrazine Tyrosine Kinase Inhibitors |
| 07/16/2009 | US20090181924 Compositions Comprising Glycosaminoglycans of Low Viscosity and Use of Said Composition in Therapy of Chronic Cystitis |
| 07/16/2009 | US20090181904 Method for regulating nutrient absorption with ginsenosides |
| 07/16/2009 | US20090181114 Chia seed beverage and related method |
| 07/16/2009 | US20090181109 Nanoveson™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases |
| 07/16/2009 | US20090181099 Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |